한글목차

세계의 시각 장애 시장은 2025년에 52억 4,000만 달러로 추정되며, 2032년에는 95억 9,000만 달러에 달할 것으로 예측되며, 2025-2032년에 CAGR 9.0%로 성장할 전망입니다.

도표. 2025년 시각 장애 시장 점유율(%), 지역별

세계 시각 장애 시장은 2025-2032년 동안 강력한 성장세를 보일 것으로 예측됩니다. 시각 장애는 안경과 같은 일반적인 수단으로 교정할 수 없는 질병, 장애, 부상으로 인한 시력 제한을 의미합니다. 시각장애의 일반적인 원인으로는 백내장, 녹내장, 노인황반변성, 당뇨병성 망막증 등이 있습니다. 세계 인구의 급속한 고령화, 당뇨병 유병률 증가, 도시화가 세계 시각 장애 시장을 촉진하는 주요 요인입니다. 그러나 높은 치료 비용과 농촌 지역의 낮은 인지도가 시장 성장을 저해하는 요인으로 작용하고 있습니다. 줄기세포 치료나 유전자 치료와 같은 새로운 기술 혁신은 기존의 방법으로는 치료할 수 없는 증상을 치료하는 데 유망하며, 새로운 길을 열어줄 것입니다.

시장 역학

세계 시각장애 시장은 안질환에 취약한 노년층의 급증에 의해 주도되고 있습니다. 유엔에 따르면 60세 이상 인구는 2050년까지 2배 이상 증가하여 21억 명에 육박할 것으로 예상됩니다. IDF에 따르면 2020년 세계 성인 인구의 9.3%가 당뇨병을 앓고 있으며, 2045년에는 10.9%로 증가할 것으로 예상됩니다. 도시화로 인해 디지털 기기 과다 사용과 같은 건강에 해로운 생활 습관은 눈에 부담을 주며, 특히 젊은 연령층에서 근시 위험이 높아집니다. 그러나 첨단 치료의 고비용, 원격지에서의 제한된 의료 접근성, 낮은 인지도 등이 시장 성장을 저해하는 요인으로 작용하고 있습니다. 기존의 방법으로는 치료할 수 없는 만성 안과 질환을 치료하기 위한 줄기세포 치료와 유전자 치료의 개발은 유리한 기회를 제공합니다.

본 조사의 주요 특징

• 세계의 시각 장애 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR%)을 게재하고 있습니다.
• 또한 다양한 부문에 걸친 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 인사이트를 제공합니다.
• 세계 시각장애 시장의 주요 기업 개요을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등의 파라미터를 기준으로 정리하여 수록했습니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 시각 장애 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 리포트 설명
  • 시장의 정의와 범위
• 개요
• COM(Coherent Opportunity Map)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 규제 시나리오
• 인수와 제휴 시나리오
• 자금조달과 투자
• PEST 분석
• Porter의 산업 분석

제4장 세계의 시각 장애 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 구상
• 시장에 대한 COVID-19의 영향

제5장 세계의 시각 장애 시장, 제품 유형별, 2020-2032년(10억 달러)

• 서론
• 교육용 디바이스와 소프트웨어
• 점자 복사기와 점자 필기기
• 점자 컴퓨터
• 수학·과학 기기
• 독서기
• 기타
• 이동 기기
• 지팡이
• 기타
• 저시력 디바이스
• 스마트 글래스
• VTS 링크
• 확대 랜즈
• 기타
• 기타

제6장 세계의 시각 장애 시장, 최종사용자별, 2020-2032년(10억 달러)

• 서론
• 맹아 학교와 훈련시설
• 기업과 사회 단체
• 개인 사용
• 병원
• 기타

제7장 세계의 시각 장애 시장, 지역별, 2020-2032년(10억 달러)

• 서론
• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제8장 경쟁 구도

• 기업 개요
  • OrCam Technologies
  • Sangamo Therapeutics, Inc.
  • Freedom Scientific, Inc.
  • HumanWare Group
  • Enhanced Vision Systems(EVS)
  • Vispero
  • Eschenbach Optik GmbH
  • LVI Low Vision International
  • eSight Corporation
  • IrisVision
  • Rejoin Technology Co., Ltd
  • Zoomax Technology Co., Limited
  • Dolphin Computer Access Ltd
  • Aumed Group Corp.
  • Topcon Corporation
  • Microsoft Corporation
  • NovaVision, Inc.
  • Telesensory Corporation
  • Second Sight Medical Products, Inc.

제9장 운명의 수레바퀴

• 운명의 수레바퀴
• COM(Coherent Opportunity Map)

제10장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Visual Impairment Market is estimated to be valued at USD 5.24 Bn in 2025 and is expected to reach USD 9.59 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.0% from 2025 to 2032.

Figure. Visual Impairment Market Share (%), By Region 2025

Global visual impairment market is projected to witness robust growth during 2025-2032. Visual impairment refers to a limitation in the ability to see caused due to diseases, disorders, or injuries which cannot be corrected by usual means like glasses. Some common causes of visual impairment include cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy among others. Rapidly aging global population, rising prevalence of diabetes, and urbanization are the key factors driving the global visual impairment market. However, high cost of treatment and lack of awareness in rural areas hinders the market growth. New innovations in treatments like stem cell therapy and gene therapy holds promise to treat conditions not addressable by conventional methods, thereby opening new avenues.

Market Dynamics:

The global visual impairment market is driven by the rapidly growing geriatric population which are more prone to eye diseases. As per UN, United Nations the number of people aged 60 years and older is expected to more than double by 2050 and reach nearly 2.1 billion. Rising prevalence of diabetes also fuels the market. According to IDF, 9.3% of the global adult population had diabetes in 2020 and it is projected to rise to 10.9% by 2045. Urbanization leads to unhealthy lifestyle habits like the overuse of digital devices which strains eyes and increases risk of myopia especially among the younger population. However, high cost of advanced treatments, limited healthcare access in remote areas, and lack of awareness hinders the market growth. Development of stem cell therapy and gene therapy to treat chronic eye conditions not addressable by traditional methods offers lucrative opportunities.

Key Features of the Study:

• This report provides in-depth analysis of the global visual impairment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global visual impairment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novartis AG, Bausch Health Companies Inc., Acucela Inc., Nicox SA, Santen Pharmaceutical Co. Ltd., Allergan, and F. Hoffmann-La Roche AG
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global visual impairment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global visual impairment market

Detailed Segmentation-

• By Product Type
  • Educational Devices & Software:
  • Braille Duplicators and Writers
  • Braille Computers
  • Mathematical & Science Devices
  • Reading Machines
  • Others
  • Mobility Devices
  • Canes
  • Others
  • Low Vision Devices
  • Smart Glasses
  • VTS Link
  • Magnifying Lenses
  • Others
  • Others
• By End Users
  • Blind Schools & Training institutes
  • Enterprises & Social Organizations
  • Personal Use
  • Hospitals
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • OrCam Technologies
  • Freedom Scientific, Inc.
  • HumanWare Group
  • Enhanced Vision Systems (EVS)
  • Vispero
  • Eschenbach Optik GmbH
  • LVI Low Vision International
  • eSight Corporation
  • IrisVision
  • Rejoin Technology Co., Ltd
  • Zoomax Technology Co., Limited
  • Dolphin Computer Access Ltd
  • Aumed Group Corp.
  • Topcon Corporation
  • Microsoft Corporation
  • NovaVision, Inc.
  • Telesensory Corporation
  • Second Sight Medical Products, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Visual Impairment Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Visual Impairment Market, By Product Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Educational Devices & Software
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Braille Duplicators and Writers
• Braille Computers
• Mathematical & Science Devices
• Reading Machines
• Others
• Mobility Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Canes
• Others
• Low Vision Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Smart Glasses
• VTS Link
• Magnifying Lenses
• Others
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Visual Impairment Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Blind Schools & Training institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Enterprises & Social Organizations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Personal Use
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Visual Impairment Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • OrCam Technologies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sangamo Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Freedom Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • HumanWare Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Enhanced Vision Systems (EVS)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Vispero
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eschenbach Optik GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LVI Low Vision International
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • eSight Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • IrisVision
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Rejoin Technology Co., Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zoomax Technology Co., Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dolphin Computer Access Ltd
  • Aumed Group Corp.
  • Topcon Corporation
  • Microsoft Corporation
  • NovaVision, Inc.
  • Telesensory Corporation
  • Second Sight Medical Products, Inc.

9. Wheel of Fortune

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. Reference and Research Methodology

• References
• Research Methodology
• About us and Sales Contact